Systemic ozone therapy and its immunomodulatory effects in COVID-19 patients
- Авторлар: Fedorova T.A.1, Krechetova L.V.1, Bakuridze E.M.1, Rogachevsky O.V.1, Zaitsev V.Y.2, Strelnikova E.V.1, Pyregov A.V.1, Kozachenko I.F.1, Esayan R.M.1, Khamidulina K.G.1, Inviyaeva E.V.1, Vtorushina V.V.1, Chudzhaeva E.B.1
-
Мекемелер:
- Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- LLC Firm Medozon
- Шығарылым: № 8 (2022)
- Беттер: 85-94
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249540
- DOI: https://doi.org/10.18565/aig.2022.8.85-94
- ID: 249540
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Tatiana Fedorova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_fyodorova@oparina4.ru
Dr. Med. Sci., Professor, Head of Transfusional Department
Lyubov Krechetova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_krechetova@oparina4.ru
Dr. Med. Sci., Head of the Laboratory of Clinical Immunology
Eteri Bakuridze
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: e_bakuridze@oparina4.ru
PhD, Head of the Clinic at the Department of Transfusion and Extracorporeal Hemocorrection
Oleg Rogachevsky
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: о_rogachevskiy@oparina4.ru
Dr. Med. Sci., Head of the Department of Extracorporal Methods of Treatment and Detoxification, Professor at the Department of Anesthesiology and Resuscitation
Vladimir Zaitsev
LLC Firm MedozonPhD (Chemistry), Director
Elena Strelnikova
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: e_strelnikova@oparina4.ru
PhD, doctor at the Department of Extracorporal Methods of Treatment and Detoxification
Aleksey Pyregov
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_pyregov@oparina4.ru
Dr. Med. Sci., Professor, Director of the Institute of Anesthesiology and Resuscitation
Irena Kozachenko
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: i_kozachenko@oparina4.ru
PhD, Leading Researcher at the Gynecological Department
Rosa Esayan
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: r_esayan@oparina4.ru
PhD, endocrinologist, Head of the Therapeutic Department
Ksenia Khamidulina
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: k_bykova@oparina4.ru
PhD, Researcher at the Department of Extracorporeal Methods of Treatment and Detoxification
Elena Inviyaeva
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: e_inviyaeva@oparina4.ru
PhD, Senior Researcher at the Laboratory of Clinical Immunology
Valentina Vtorushina
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_vtorushina@oparina4.ru
PhD, clinical laboratory diagnostics doctor
Elzyata Chudzhaeva
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: chudzhaeva@mail.ru
the nurse at the Therapeutic Department
Әдебиет тізімі
- Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID 19. Nat. Rev. Microbiol. 2021; 19(3): 141-54. https://dx.doi.org/10.1038/s41579-020-00459-7
- Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020; 368(6490): 473-4. https://dx.doi.org/10.1126/science.abb8925.
- Conti P., Ronconi G., Caraffa A., GaUenga C.E., Ross R., Frydas I. et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020; 34(2): 327-31. https://dx.doi.org/10.23812/CONTI-E.
- Martinez-Sanchez G., Schwartz A., Donna V.D. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel). 2020; 9(5): 389. https://dx.doi.org/10.3390/antiox9050389.
- PercivaUe E., Clerici M., Cassaniti I., Vecchio Nepita E., Marchese P., Olivati D. et al. SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation. J. Hosp. Infect. 2021; 110: 33-6. https://dx.doi.org/10.1016/j.jhin.2021.01.014.
- Yano H., Nakano R., Suzuki Y., Nakano A., Kasahara K., Hosoi H. Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone treatment. J. Hosp. Infect. 2020; 106(4): 837-8. https://dx.doi.org/10.1016/j.jhin.2020.10.004.
- Cenci A., Macchia I., La Sorsa V., Sbarigia C., Di Donna V., Pietraforte D. Mechanisms of action of ozone therapy in emerging viral diseases: immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2. Front. Microbiol. 2022; 13: 871645. https://dx.doi.org/10.3389/fmicb.2022.871645.
- Chirumbolo S., Valdenassi L., Simonetti V., Bertossi D., Ricevuti G., Franzini M. et al. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int. Immunopharmacol. 2021; 96: 107777. https://dx.doi.org/10.1016/j.intimp.2021.107777.
- Министерство здравоохранения Российской Федерации. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (covid-19). Версия 6 (28.04.2020).
- Терапевтический профиль. Протокол оценки тяжести состояния пациента (NEWS). Доступно по: https://euat.ru/upload/images/1586077839.pdf?ysclid=l70h8s2eb9327079697
- Федорова Т.А., Бакуридзе Э.М., Пырегов А.В., Гаврилова Т.Ю., Козаченко И.Ф., Есаян Р.М., Хамидулина К.Г., Хачатрян Н.А., Иванец Т.Ю., Кречетова Л.В., Инвияева Е.В., Вторушина В.В., Безнощенко О.С., Нечипуренко Д.Ю., Береснева Е.А. Возможности применения системной озонотерапии у пациентов с COVID-19 инфекцией. Биорадикалы и антиоксиданты. 2021; 8(2): 8-24.
- Классификация степени тяжести вирусной/CОV-19 пневмонии по КТ. Доступно по: http://www.secondopinions.ru Дата обращения: 27.05.2020.
- Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203(2): 631-7. https://dx.doi.org/10.1002/path.1570.
- Hernandez A., Papadakos P.J., Torres A., Gonzalez D.A., Vives M., Ferrando C. et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev. Esp. Anestesiol. Reanim. (Engl. Ed.). 2020; 67(5): 245-52. https://dx.doi.org/10.1016/j.redar.2020.03.004.
- The ZOE Health Study. How long does COVID-19 last? UK: London; 2020. Available at: https://covid19.joinzoe.com/post/covid-long-term?fbclid= IwAR1RxIcmmdL-EFjh_aI-. Accessed 15.03.2021.
- Wang W., Ye L., Ye L., Li B., Gao B., Zeng Y. et al. Up-regulation of IL-6 and TNF-a induced by SARS-coronavirus spike protein in murine macrophages via NF-xappaB pathway. Virus Res. 2007; 128(1-2): 1-8. https://dx.doi.org/10.1016/j.virusres.2007.02.007.
- Olbei M., Hautefort I., Modos D., Treveil A., Poletti M., Gul L. et al. SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely ill patients. Front. Immunol. 2021; 12: 629193. https://dx.doi.org/10.3389/fimmu.2021.629193.
- Gubernatorova E.O., Gorshkova E.A., Polinova A.I., Drutskaya M.S. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020; 53: 13-24. https://dx.doi.org/10.1016/j.cytogfr.2020.05.009.
- Озон против COVID-19 - Ассоциация Российских Озонотерапевтов. Потенциальное использование озона при инфекции SARS-CoV-2/COVID-19. 2020. Доступно по: www.ozonetherapy.ru
- Rowen R., Robins H. A plausible “penny” costing effective treatment for corona virus - ozone therapy. J. Infect. Dis. Epidemiol. 2020; 6(2): 113. https://dx.doi.org/10.23937/2474-3658/1510113.
- Franzini M., Valdenassi L., Ricevuti G., Chirumbolo S., Depfenhart M., Bertossi D., Tirelli U. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int. Immunopharmacol. 2020; 88: 106879. https://dx.doi.org/10.1016/j.intimp.2020.106879.
- Hamilton J.A., Whitty G.A., Stanton H., Meager A. Effects of macrophage-colony stimulating factor on human monocytes: induction of expression of urokinase-type plasminogen activator, but not of secreted prostaglandin E2, interleukin-6, interleukin-1, or tumour necrosis factor-alpha. J. Leukoc. Biol. 1993; 53(6): 707-14. https://dx.doi.org/10.1002/jlb.53.6.707.
- Takahashi G.W., Andrews D.F. 3rd, Lilly M.B., Singer J.W., Alderson M.R. Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes. Blood. 1993; 81(2): 357-64.
- Martinez-Sanchez G. Mechanisms of action of O3. Genomic pathways. Ozone Ther. Glob. J. 2019; 9(1): 21-2.
- Martinez-Sanchez G., Delgado-Roche L. Up-date on the mechanisms of action of ozone through the modification of cellular signaling pathways. Role of Nrf2 and NFkb. Rev. Esp. Ozonoterapia. 2017; 7: 17-8.
- Li W., Khor T.O., Xu C., Shen G., Jeong W.S., Yu S. et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008; 76(11): 1485-9. https://dx.doi.org/10.1016/j.bcp.2008.07.017.
- Li Q., Verma I.M. NF-xappaB regulation in the immune system. Nat. Rev. Immunol. 2002; 2(10): 725-34. https://dx.doi.ois/10.1038/nri910.
- Araimo F., Imperiale C., Tordiglione P., Ceccarelli G., Borrazzo C., Alessandri F. et al. Ozone as adjuvant support in the treatment of COVID-19: a preliminary report of probiozovid trial. J. Med. Virol. 2021; 93(4): 2210-20. https://dx.doi.org/10.1002/jmv.26636.
- Хаммад Е.В., Никитин И.Г., Федорова К.В. Применение озонотерапии у пациентов с новой коронавирусной инфекцией COVID-19. Вестник восстановительной медицины. 2020; 5(99): 94-100. [Hammad E.V., Nikitin I.G., Fedorova K.V. Ozone Therapy in Patients with the New Coronavirus Infection COVID-19. Bulletin of Restorative Medicine. 2020; 5(99): 94-100. (in Russian)]. https://dx.doi.org/10.38025/2078-1962-2020-99-5-94-100.